A metaanalysis of controlled trials of neuroleptic treatment in dementia.
about
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Atypical antipsychotics for aggression and psychosis in Alzheimer's diseaseTrazodone for agitation in dementiaRecognition and Management of Behavioral Disturbances in DementiaPrevalence of physical and verbal aggressive behaviours and associated factors among older adults in long-term care facilities.Psychosis in Alzheimer's diseaseAssessment and management of behavioral and psychological symptoms of dementiaBuspirone for the treatment of dementia with behavioral disturbance.Continuous use of antipsychotics and its association with mortality and hospitalization in institutionalized Chinese older adults: an 18-month prospective cohort study.Behavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint.Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature.Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.Genetics of Psychosis in Alzheimer Disease.The social consequences for families with Alzheimer's disease patients: potential impact of new drug treatment.North of England evidence based guidelines development project: guideline for the primary care management of dementiaThe biological basis of behavioral symptoms in dementia.Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone.Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized, controlled trial.Assessment and management of behavioral disturbances in Alzheimer disease.Neuropsychiatric aspects of Alzheimer's disease.Neurobiological basis of behavioral and psychological symptoms in dementia of the Alzheimer type.Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?Gabapentin for treatment of behavioral and psychological symptoms of dementia.Cholinesterase inhibitors for behavioral disturbance in dementia.Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.Successful treatment of behavioural problems in dementia using a cholinesterase inhibitor: the ethical questions.Use of neuroleptics: study of institutionalized elderly people in Montreal, Que.Approach to managing behavioural disturbances in dementia.New wine in old bottle: late-life psychosisCorrelates of behavioral disturbances and pattern of psychotropic medication use in five skilled nursing facilities.Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) studyMedication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.Improving geriatric mental health nursing care: making a case for going beyond psychotropic medications.Behavioural disturbances in the demented elderly: phenomenology, pharmacotherapy and behavioural management.Citalopram for agitation in Alzheimer's disease: design and methods.
P2860
Q21144654-FC51BEBA-9500-4379-BD89-C689C14D9F0CQ24244504-F55835E5-718E-4A92-B888-28702BE83226Q24246592-23E38137-88BB-49B0-A609-6F1AFA93376BQ24682986-46F64447-B6BB-432F-AA9A-ACEA4440D0F3Q24816181-664A19DC-C94C-4DC5-802C-1CCCA54E213EQ26824635-C2DE56EB-3FFC-459E-A5F5-94E0BAE342EDQ28088782-67C1A771-A6F9-43A7-B538-821344491D46Q30274916-5E1CE9AC-75DF-47E0-94A7-E0CECA660573Q30406882-14A0D22A-BF0F-47E7-9CC8-E9224020BD75Q30473431-2DF30930-A90B-4FF7-A222-DCE94FD6158CQ30540486-2DE220C4-19C6-4215-A002-854E8FC2AE3EQ33203719-95EB00C4-50C4-41EA-BE72-165B5BB99695Q33480648-B857651C-EB2D-444F-B07D-20A0859D237DQ33641585-7A4CDC1B-DE6C-46ED-8091-B56DC99BC91AQ33666458-B3F8B66E-F64B-474A-92AA-0A57DC8ED599Q33675759-F018F9DB-2005-4101-B396-EC29F450F68DQ33791951-3C99811D-7B30-4FD2-8E2B-A85D63B846F1Q33827881-DCE2E8F0-CC5D-4535-B078-347B0334F924Q33892947-53212105-09BD-4836-BDC5-7D7ADD29C94CQ33982645-A969ED83-CC31-4C8C-AFAF-11773E93072DQ34031223-06B41408-0C94-4DDE-98C7-EDA2AA0557ADQ34108175-69A59DD3-7806-47A3-82E2-03A2154A390CQ34122906-C562D19C-6A6A-404B-B0B1-10839D485A10Q34146983-6D660115-8B2D-4A7B-9E37-9EE31F17A139Q34219064-3D609C5D-C5BD-4829-8474-EABEA6F9E6CEQ34251448-524D0028-7AFB-4691-8116-B08F277DB1CAQ34452896-9DFA5A39-25BF-4831-9CE5-C9EE73D95A05Q34465775-13282398-1F6F-42E6-B654-B82F28BF8803Q34571959-A39241EC-07D1-4D15-A604-BDE19D0405F2Q34619215-FAC28AA1-F6A1-430B-BE6F-50AE32EED2DBQ34653780-BC47F352-B09C-4E68-8BA9-413F8C07CBF9Q34683770-5E02F9CC-B388-4EE8-AF55-DA96AA478FAFQ34976609-1E4BA691-74AA-4FB5-8941-1C478DE8B67DQ35086756-6BEF05CA-8DBE-4060-B512-73852B567E76Q35147570-AD88584B-0E4E-4DC0-8BFA-31E7AF85E049Q35185368-CE9A1D57-D9AE-441E-891C-C72816804ABBQ35201061-816F234A-436D-40CD-9312-50EDE00FD27EQ35611538-FC2FB611-46B7-4E01-BC2C-21F57BB04C33Q35653786-1CF55E11-7C5B-4ABA-9F74-0E76EDC906ECQ35905635-E8427C57-1B1F-415A-8E31-8612610C360D
P2860
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
@en
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
@nl
type
label
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
@en
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
@nl
prefLabel
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
@en
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
@nl
P2093
P1476
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
@en
P2093
Pollock VE
Schneider LS
P304
P356
10.1111/J.1532-5415.1990.TB02407.X
P407
P577
1990-05-01T00:00:00Z